健友股份：关于子公司获得美国FDA注射用维库溴铵药品增加生产场地注册批件的公告

Group 1 - The core point of the article is that Jianyou Co., Ltd. announced that its subsidiary, Meitheal Pharmaceuticals, Inc., received approval from the U.S. FDA to increase production sites for injectable Vecuronium Bromide, 10mg/vial and 20mg/vial [2][3] - The approval allows production at the Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. facility [2]